FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3039200055> ?p ?o ?g. }

• W3039200055 abstract "This study estimates the prevalence and identifies predictors of psychoactive medication use in adolescent survivors of childhood cancer (aged 12-18 years) and its associations with functional outcomes at young adulthood (aged 18-28 years).This retrospective cohort study includes 5665 adolescent survivors of childhood cancer at no less than 5 years postdiagnosis (53.8% male, median age = 15 years, interquartile range [IQR] = 13-16 years) and 921 adolescent sibling controls. Parent-reported psychoactive medication use during adolescence was collected at baseline. After a median of 8 years, functional outcomes and social attainment were self-reported during adulthood (n = 3114, median age = 22 years, IQR = 20-24 years). Multivariable log-binomial models evaluated associations among risk factors, medication use, and adult outcomes.Higher prevalence of psychoactive medication use was reported in survivors compared with siblings (18.3% vs 6.6%; 2-sided P < .001), with trends for increasing antidepressant and stimulant use in recent treatment eras. After adjusting for cancer treatment and baseline cognitive problems, psychoactive medication use during adolescence was associated with impaired task efficiency (relative risk [RR] = 1.20, 95% confidence interval [CI] = 1.01 to 1.43) and memory (RR = 1.27, 95% CI = 1.05 to 1.52) during adulthood. Survivors who reported continued use of medications from adolescence to adulthood demonstrated poorer emotional regulation (RR = 1.68, 95% CI = 1.24 to 2.27) and organization (RR = 1.82, 95% CI = 1.28 to 2.59) compared with nonusers. Adolescent opioid use was associated with somatization symptoms (RR = 1.72, 95% CI = 1.09 to 2.73) during adulthood, after adjusting for cancer treatment and baseline behavioral problems. They were also more likely to not complete college (RR = 1.21, 95% CI = 1.04 to 1.41) or work full-time (RR = 1.60, 95% CI = 1.23 to 2.08) compared with nonusers.Use of psychoactive medication is more prevalent among adolescent survivors compared with siblings and does not normalize adult outcomes, as evidenced by poorer functional outcomes during young adulthood." @default.
• W3039200055 created "2020-07-10" @default.
• W3039200055 creator A5006774665 @default.
• W3039200055 creator A5021808043 @default.
• W3039200055 creator A5038361086 @default.
• W3039200055 creator A5059262359 @default.
• W3039200055 creator A5061133601 @default.
• W3039200055 creator A5064240580 @default.
• W3039200055 creator A5065573166 @default.
• W3039200055 creator A5067443773 @default.
• W3039200055 creator A5071037763 @default.
• W3039200055 creator A5082334822 @default.
• W3039200055 creator A5082548734 @default.
• W3039200055 creator A5084390679 @default.
• W3039200055 creator A5087384700 @default.
• W3039200055 date "2020-06-29" @default.
• W3039200055 modified "2023-10-01" @default.
• W3039200055 title "Prescription Psychoactive Medication Use in Adolescent Survivors of Childhood Cancer and Association With Adult Functional Outcomes" @default.
• W3039200055 cites W100981749 @default.
• W3039200055 cites W1564896508 @default.
• W3039200055 cites W1806299425 @default.
• W3039200055 cites W1902257097 @default.
• W3039200055 cites W2004799731 @default.
• W3039200055 cites W2007405419 @default.
• W3039200055 cites W2029724069 @default.
• W3039200055 cites W2058217833 @default.
• W3039200055 cites W2083500054 @default.
• W3039200055 cites W2084974814 @default.
• W3039200055 cites W2086775762 @default.
• W3039200055 cites W2101807916 @default.
• W3039200055 cites W2104044738 @default.
• W3039200055 cites W2105984088 @default.
• W3039200055 cites W2113202488 @default.
• W3039200055 cites W2121411489 @default.
• W3039200055 cites W2259477894 @default.
• W3039200055 cites W2321120095 @default.
• W3039200055 cites W2323716083 @default.
• W3039200055 cites W2415263224 @default.
• W3039200055 cites W2535887078 @default.
• W3039200055 cites W2608692976 @default.
• W3039200055 cites W2752414510 @default.
• W3039200055 cites W2770100081 @default.
• W3039200055 doi "https://doi.org/10.1093/jncics/pkaa057" @default.
• W3039200055 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7583158" @default.
• W3039200055 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33134833" @default.
• W3039200055 hasPublicationYear "2020" @default.
• W3039200055 type Work @default.
• W3039200055 sameAs 3039200055 @default.
• W3039200055 citedByCount "7" @default.
• W3039200055 countsByYear W30392000552021 @default.
• W3039200055 countsByYear W30392000552022 @default.
• W3039200055 countsByYear W30392000552023 @default.
• W3039200055 crossrefType "journal-article" @default.
• W3039200055 hasAuthorship W3039200055A5006774665 @default.
• W3039200055 hasAuthorship W3039200055A5021808043 @default.
• W3039200055 hasAuthorship W3039200055A5038361086 @default.
• W3039200055 hasAuthorship W3039200055A5059262359 @default.
• W3039200055 hasAuthorship W3039200055A5061133601 @default.
• W3039200055 hasAuthorship W3039200055A5064240580 @default.
• W3039200055 hasAuthorship W3039200055A5065573166 @default.
• W3039200055 hasAuthorship W3039200055A5067443773 @default.
• W3039200055 hasAuthorship W3039200055A5071037763 @default.
• W3039200055 hasAuthorship W3039200055A5082334822 @default.
• W3039200055 hasAuthorship W3039200055A5082548734 @default.
• W3039200055 hasAuthorship W3039200055A5084390679 @default.
• W3039200055 hasAuthorship W3039200055A5087384700 @default.
• W3039200055 hasBestOaLocation W30392000551 @default.
• W3039200055 hasConcept C118552586 @default.
• W3039200055 hasConcept C119060515 @default.
• W3039200055 hasConcept C126322002 @default.
• W3039200055 hasConcept C187212893 @default.
• W3039200055 hasConcept C201903717 @default.
• W3039200055 hasConcept C205545832 @default.
• W3039200055 hasConcept C44249647 @default.
• W3039200055 hasConcept C71924100 @default.
• W3039200055 hasConcept C82789193 @default.
• W3039200055 hasConceptScore W3039200055C118552586 @default.
• W3039200055 hasConceptScore W3039200055C119060515 @default.
• W3039200055 hasConceptScore W3039200055C126322002 @default.
• W3039200055 hasConceptScore W3039200055C187212893 @default.
• W3039200055 hasConceptScore W3039200055C201903717 @default.
• W3039200055 hasConceptScore W3039200055C205545832 @default.
• W3039200055 hasConceptScore W3039200055C44249647 @default.
• W3039200055 hasConceptScore W3039200055C71924100 @default.
• W3039200055 hasConceptScore W3039200055C82789193 @default.
• W3039200055 hasFunder F4320337351 @default.
• W3039200055 hasLocation W30392000551 @default.
• W3039200055 hasLocation W30392000552 @default.
• W3039200055 hasLocation W30392000553 @default.
• W3039200055 hasOpenAccess W3039200055 @default.
• W3039200055 hasPrimaryLocation W30392000551 @default.
• W3039200055 hasRelatedWork W11122704 @default.
• W3039200055 hasRelatedWork W18145365 @default.
• W3039200055 hasRelatedWork W19489455 @default.
• W3039200055 hasRelatedWork W2671146 @default.
• W3039200055 hasRelatedWork W4346409 @default.
• W3039200055 hasRelatedWork W4560225 @default.
• W3039200055 hasRelatedWork W6668650 @default.
• W3039200055 hasRelatedWork W6986156 @default.
• W3039200055 hasRelatedWork W8808446 @default.

• next